Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL.

Sironi, L

Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL. [electronic resource] - Arteriosclerosis, thrombosis, and vascular biology Jan 1996 - 89-96 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1079-5642

10.1161/01.atv.16.1.89 doi


Carcinoma, Hepatocellular--metabolism
Culture Media, Conditioned
Gene Expression Regulation--drug effects
Humans
Lipoproteins, VLDL--pharmacology
Liver Neoplasms--metabolism
Plasminogen Activator Inhibitor 1--biosynthesis
RNA, Messenger--metabolism
Receptors, LDL--physiology
Triglycerides--metabolism
Tumor Cells, Cultured